Evidence map›Paper›PMID 42316290›Full record

ArticleJournal of translational medicine2026

Functional consistency and molecular evolution: a comprehensive characterization of primary endometrial cancer-associated fibroblasts during in vitro expansion.

Lunmin Bao, Ping Wang, Daoming Wang, Xiaoduo Li, Hailong Zhang, Xiufang Wan, Rui Yuan, Nanzi Xie, Ling Lei, Qihui Cheng and 5 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lunmin Bao *Department of Laboratory Medicine, People's Hospital of Anshun City, Anshun, Guizhou, 561000, China.
Ping Wang *Department of Clinical Microbiology and Immunology, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou, 550000, China.
Daoming Wang *Department of Clinical Microbiology and Immunology, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou, 550000, China.
Xiaoduo LiDepartment of Laboratory Medicine, People's Hospital of Anshun City, Anshun, Guizhou, 561000, China.
Hailong ZhangDepartment of Laboratory Medicine, People's Hospital of Anshun City, Anshun, Guizhou, 561000, China.
Xiufang WanDepartment of Clinical Microbiology and Immunology, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou, 550000, China.
Rui YuanDepartment of Clinical Microbiology and Immunology, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou, 550000, China.
Nanzi XieDepartment of Pathology, People's Hospital of Anshun City, Anshun, Guizhou, 561000, China.
Ling LeiDepartment of Gynaecology, People's Hospital of Anshun City, Anshun, Guizhou, 561000, China.
Qihui ChengDepartment of Gynaecology, People's Hospital of Anshun City, Anshun, Guizhou, 561000, China.
Xiaopei LeiDepartment of Gynaecology, People's Hospital of Anshun City, Anshun, Guizhou, 561000, China.
Xian'e CaoDepartment of Immunology, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 550000, China.
Haibing DaiDepartment of Clinical Microbiology and Immunology, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou, 550000, China.
Ting ZhengDepartment of Clinical Microbiology and Immunology, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou, 550000, China.
Hongmei JiangDepartment of Clinical Microbiology and Immunology, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou, 550000, China. jianghongmei@gmc.edu.cn.ORCID 0000-0001-7427-5566

Funding

Anshun Science and Technology Bureau Anshikeshe﹝2024﹞03Anshun Science and Technology Bureau Anshikeyizi﹝2026﹞17Guizhou Nursing Vocational College gzhlyj2025-01National Natural Science Foundation of China 82360423
6 · The paper itself

Abstract

backgroundCancer-associated fibroblasts (CAFs) are critical components of the tumor microenvironment in endometrial cancer (EC). Primary isolation and culture of CAFs serve as the standard method for investigating their biological roles. However, it remains unclear whether prolonged in vitro culture alters the intrinsic properties of CAFs, potentially affecting experimental reproducibility. This study aims to evaluate the phenotypic and transcriptomic evolution of primary EC-derived CAFs across different passages.

methodsCAFs were isolated from human EC tissues using enzymatic digestion and differential adherence. Cells at passages 1 (P1), 5 (P5), and 10 (P10) were compared. Biological phenotypes, including proliferation, migration, apoptosis, senescence, and cytokine secretion, were assessed. The effects of CAF-conditioned medium (CM) on the proliferation and invasion of EC cell lines (ISHIKAWA and HEC-1 A) were evaluated. Furthermore, RNA sequencing (RNA-seq) was performed to uncover molecular alterations, followed by functional enrichment and subtype analyses. Additional validation experiments, including ROS detection, NF-κB activation analysis, H₂O₂-induced oxidative stress modeling, and NAC or TPCA-1 intervention, were conducted to investigate the mechanism underlying passage-associated inflammatory drift.

resultsCAFs maintained a consistent spindle-shaped morphology and expression of specific markers (Vimentin/FAP) from P1 to P10. Functional assays demonstrated no significant differences in proliferation, migration, or senescence rates across passages. Crucially, CAFs at all passages exhibited comparable efficacy in promoting the proliferation, migration, and invasion of EC cells. However, transcriptomic profiling revealed profound reprogramming, with 1,300 core genes differentially expressed in P5/P10 compared to P1. While pathways related to extracellular matrix remodeling (myCAF signature) remained stable, establishing the molecular basis for sustained invasion support, passaged CAFs progressively exhibited reduced antigen-presenting signatures and acquired a pro-inflammatory iCAF-like phenotype. Mechanistically, late-passage CAFs showed increased ROS accumulation, enhanced P65 phosphorylation and nuclear translocation, and upregulated inflammatory mediators, including IL6, CXCL1, CXCL2, and CCL2. H₂O₂ treatment partially mimicked this inflammatory phenotype in P1 CAFs, whereas NAC or TPCA-1 attenuated inflammatory activation in P10 CAFs.

conclusionsPrimary endometrial CAFs retain core tumor-supporting phenotypes and myofibroblastic characteristics up to passage 10, validating their utility as reliable in vitro models for invasion and metastasis studies. However, high-passage CAFs exhibit a culture-associated inflammatory transcriptional drift driven, at least in part, by ROS/NF-κB activation, together with reduced immunogenic features. These findings provide essential guidelines for the standardization of CAF-based research models and caution against using high-passage CAFs for immune-interaction or inflammation-related studies.

Indexed as

Cancer-Associated FibroblastsEndometrial NeoplasmsApoptosisCell Line, TumorCell MovementCell ProliferationCellular SenescenceCulture Media, ConditionedCytokinesFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansNeoplasm InvasivenessNF-kappa BOxidative StressCulture Media, ConditionedCytokinesNF-kappa BReactive Oxygen SpeciesCancer-associated fibroblastsEndometrial cancerPrimary cultureTranscriptomic reprogramming

Identifiers

PMID42316290
PMCPMC13495234

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.